Research partners

DCTI mission

DCTI is a research initiative to improve beta-cell replacement therapy and to make this therapy accessible for more patients with diabetes. The main research goals are to increase the availability of high quality insulin-producing cells and the development of alternative transplantation sites and to identify factors for long-term islet function and survival with the use of biomaterials.

Five research areas contribute to this goal:

Schematic overview of overarching goal with time line and research areas

New Partners

Several DCTI partners have joined RegMed XB ( to build on the knowledge generated within DCTI.


Eelco de Koning (Scientific Director)

Margot Beukers (Managing Director)